Aurobindo Pharma Ltd — Irbesartan Exporter Profile
Indian Pharmaceutical Exporter · #7 for Irbesartan · $2.7M export value · DGFT Verified
Aurobindo Pharma Ltd is the #7 Indian exporter of Irbesartan with $2.7M in export value and 251 verified shipments. Aurobindo Pharma Ltd holds a 2.5% market share in Irbesartan exports across 4 countries.
Aurobindo Pharma Ltd — Irbesartan Export Profile: Buyers & Destinations
Where Does Aurobindo Pharma Ltd Export Irbesartan?
| Country | Value | Shipments | Share |
|---|---|---|---|
| FRANCE | $2.7M | 126 | 77.1% |
| UNITED KINGDOM | $529.6K | 39 | 14.9% |
| MALTA | $285.0K | 194 | 8.0% |
| SPAIN | $3.0K | 1 | 0.1% |
Aurobindo Pharma Ltd exports Irbesartan to 4 countries. The largest destination is FRANCE accounting for 77.1% of Aurobindo Pharma Ltd's Irbesartan shipments, followed by UNITED KINGDOM (14.9%) and MALTA (8.0%). These destinations reflect Aurobindo Pharma Ltd's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Irbesartan from Aurobindo Pharma Ltd?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| ARROW GENERIQUES, | FRANCE | $1.8M | 84 |
| ARROW GENERIQUES | FRANCE | $824.3K | 36 |
| MILPHARM LIMITED | UNITED KINGDOM | $400.1K | 24 |
| APL SWIFT SERVICES (MALTA) LTD., | MALTA | $148.3K | 69 |
| GEODIS FF FRANCE P/O AGENCE DE LYON | FRANCE | $83.9K | 3 |
| APL SWIFT SERVICES MALTA LTD | MALTA | $82.7K | 32 |
| MILPHARM LIMITED, | UNITED KINGDOM | $59.0K | 7 |
| GEODIS FF FRANCE | FRANCE | $42.5K | 2 |
| MILPHARM LIMITED ALLOGA UKAMBER PARK | UNITED KINGDOM | $36.9K | 2 |
| APL SWIFT SERVICES(MALTA) LIMITED | MALTA | $34.4K | 7 |
Aurobindo Pharma Ltd supplies Irbesartan to 19 buyers globally. The largest buyer is ARROW GENERIQUES, (FRANCE), followed by ARROW GENERIQUES (FRANCE) and MILPHARM LIMITED (UNITED KINGDOM). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Irbesartan Export Value and How Much Does Aurobindo Pharma Ltd Contribute?
India exported $58.2M worth of Irbesartan through 2,669 shipments from 123 suppliers to 68 countries, serving 366 buyers globally. Aurobindo Pharma Ltd contributes $2.7M to this total, accounting for 2.5% of India's Irbesartan exports. Aurobindo Pharma Ltd ships Irbesartan to 4 countries through 19 buyers.
What Is the Average Shipment Value for Aurobindo Pharma Ltd's Irbesartan Exports?
Aurobindo Pharma Ltd's average Irbesartan shipment value is $10.7K per consignment, based on 251 shipments totaling $2.7M. The largest destination is FRANCE (77.1% of Aurobindo Pharma Ltd's Irbesartan exports).
How Does Aurobindo Pharma Ltd Compare to Other Indian Irbesartan Exporters?
Aurobindo Pharma Ltd ranks #7 among 123 Indian Irbesartan exporters with a 2.5% market share. The top 3 exporters are MYLAN LABORATORIES LIMITED ($10.8M), MACLEODS PHARMACEUTICALS LTD ($8.9M), SUN PHARMACEUTICAL INDUSTRIES LIMITED ($8.3M). Aurobindo Pharma Ltd processed 251 shipments to 4 destination countries.
What Irbesartan Formulations Does Aurobindo Pharma Ltd Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| IRBESARTAN TABLETS 150MG (IRBESARTAN ARR | $240.5K | 6 |
| IRBESARTAN/HYDROCHLOROTHIZIDE TABLETS 30 | $233.8K | 10 |
| IRBESARTAN TABLETS 300MG(IRBESARTAN ARRO | $156.9K | 6 |
| IRBESARTAN/HYDROCHLOROTHIZIDE TABLETS 300/25MG(IRBESARTAN HYDROCHLOROTHIAZIDE ARROW300 MG/25 MG,COMPRIM PELLICUL)9X10'SNOS | $140.2K | 6 |
| IRBESARTAN TABLETS 150MG(Irbesartan 150 | $100.2K | 4 |
| IRBESARTAN TABLETS 300MG (IRBESARTAN 300MG TABLETS) 2X14'S | $86.7K | 3 |
| IRBESARTAN/HYDROCHLOROTHIZIDE TABLETS300 | $85.3K | 5 |
| IRBESARTAN TABLETS 300MG (IRBESARTAN 300MG TABLETS)2X14'S | $77.3K | 2 |
| IRBESARTAN TABLETS 150MG(IRBESARTAN ARRO | $62.0K | 3 |
| IRBESARTAN/HYDROCHLOROTHIZIDE TABLETS 300/12.5MG (IRBESARTAN HYDROCHLOROTHIAZIDE ARROW 300 MG/12,5 MG, COMPRIM PELLICUL) | $61.0K | 2 |
Aurobindo Pharma Ltd exports 249 distinct Irbesartan formulations including tablets, capsules, syrups, and combination drugs. The top formulation is IRBESARTAN TABLETS 150MG (IRBESARTAN ARR with 6 shipments worth $240.5K.
Regulatory Requirements: Exporting Irbesartan to Key Markets
What Aurobindo Pharma Ltd must comply with to export Irbesartan to its top destination countries
United Kingdom — MHRA
Approval Process
Post-Brexit UK Marketing Authorisation via national procedure. Separate from EU approval since January 2021.
Timeline: 12–15 months
GMP & Export Requirements
UK GMP compliance; MHRA inspection of manufacturing site
Manufacturer Import Authorisation (MIA) held by UK importer; Qualified Person (QP) batch release
Note: Post-Brexit: EU GMP certificates no longer automatically valid in UK. Separate MHRA recognition required.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Aurobindo Pharma Ltd Compare to Nearest Irbesartan Exporters?
Exporters ranked immediately above and below #7 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 3 | CAPLIN POINT LABORATORIES LIMITED | $5.3M | 106 | 9 | $50.0K |
| 6 | MACLEODS PHARMACEUTICALS LIMITED | $3.6M | 89 | 7 | $40.4K |
| 7 | AUROBINDO PHARMA LTD ★ | $2.7M | 251 | 4 | $10.7K |
| 8 | ZYDUS LIFESCIENCES LIMITED | $2.4M | 162 | 6 | $15.1K |
| 9 | INTAS PHARMACEUTICALS LIMITED | $1.8M | 156 | 5 | $11.5K |
Aurobindo Pharma Ltd ranks #7 among 123 Indian Irbesartan exporters. Average shipment value of $10.7K compared to the market average of $473.0K. The closest competitors by value are CAPLIN POINT LABORATORIES LIMITED and MACLEODS PHARMACEUTICALS LIMITED.
Which Indian Ports Ship Irbesartan Exports?
| Port | Shipments | % Share |
|---|---|---|
| NHAVA SHEVA SEA (INNSA1) | 284 | 10.6% |
| SAHAR AIR | 197 | 7.4% |
| SAHAR AIR CARGO ACC (INBOM4) | 170 | 6.4% |
| JNPT/ NHAVA SHEVA SEA | 147 | 5.5% |
| DELHI AIR | 135 | 5.1% |
| DELHI AIR CARGO ACC (INDEL4) | 133 | 5.0% |
| JNPT | 129 | 4.8% |
| MUNDRA SEA (INMUN1) | 108 | 4.0% |
Market Intelligence
Latest developments and market context
Detailed market intelligence for Irbesartan — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Irbesartan shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Aurobindo Pharma Ltd matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 360 individual customs records matching Aurobindo Pharma Ltd exporting Irbesartan, covering 249 formulations to 4 countries via 19 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 68+ countries, 366+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Irbesartan Export Data from Aurobindo Pharma Ltd
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Aurobindo Pharma Ltd's Irbesartan exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Aurobindo Pharma Ltd
Company Profile
0 products · $0 total trade · 0 categories
Irbesartan Stats
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Aurobindo Pharma Ltd.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Irbesartan. For current shipment-level data, contact TransData Nexus.